Concepedia

Brett Leav

BL

43

Publications

5.7K

Citations

27

H-Index

1990

Active since

Affiliations

Moderna Therapeutics (United States)(Current)

Brigham and Women's Hospital

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Meridian Clinical Research

Brett Leav is an author at Moderna Therapeutics (United States) specializing in medicine, immunology, and vaccination.

ORCID

Top concepts

Publications per year

1990–2025

43

Publications

43

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

Evan J. Anderson, Nadine Rouphael, Alicia T. Widge et al. · New England Journal of Medicine · 2020 · 1.6K citations · Full text

Treatment with Monoclonal Antibodies against <i>Clostridium difficile</i> Toxins

Israel Lowy, Deborah C. Molrine, Brett Leav et al. · New England Journal of Medicine · 2010 · 738 citations · Full text

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

Hana M. El Sahly, Lindsey R. Baden, Brandon Essink et al. · New England Journal of Medicine · 2021 · 647 citations · Full text

Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis

Angela Choi, Matthew Koch, Laurence Chu et al. · Nature Medicine · 2021 · 446 citations · Full text

Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)

Brett Leav, Barbra M. Blair, Mark D. Leney et al. · Vaccine · 2009 · 242 citations

, , +5

Rows per page

1–5 of 43